270 related articles for article (PubMed ID: 34260681)
1. Appropriate deprescribing in older people: a challenging necessityCommentary to accompany themed collection on deprescribing.
van der Velde N; Minhas JS
Age Ageing; 2021 Sep; 50(5):1516-1519. PubMed ID: 34260681
[TBL] [Abstract][Full Text] [Related]
2. Deprescribing in older people.
Page AT; Potter K; Clifford R; Etherton-Beer C
Maturitas; 2016 Sep; 91():115-34. PubMed ID: 27451330
[TBL] [Abstract][Full Text] [Related]
3. Deprescribing medications in older people: a narrative review.
Salahudeen MS
Drugs Today (Barc); 2018 Aug; 54(8):489-498. PubMed ID: 30209443
[TBL] [Abstract][Full Text] [Related]
4. New horizons in deprescribing for older people.
Woodford HJ; Fisher J
Age Ageing; 2019 Nov; 48(6):768-775. PubMed ID: 31595290
[TBL] [Abstract][Full Text] [Related]
5. A systematic review of the evidence for deprescribing interventions among older people living with frailty.
Ibrahim K; Cox NJ; Stevenson JM; Lim S; Fraser SDS; Roberts HC
BMC Geriatr; 2021 Apr; 21(1):258. PubMed ID: 33865310
[TBL] [Abstract][Full Text] [Related]
6. What makes a multidisciplinary medication review and deprescribing intervention for older people work well in primary care? A realist review and synthesis.
Radcliffe E; Servin R; Cox N; Lim S; Tan QY; Howard C; Sheikh C; Rutter P; Latter S; Lown M; Brad L; Fraser SDS; Bradbury K; Roberts HC; Saucedo AR; Ibrahim K
BMC Geriatr; 2023 Sep; 23(1):591. PubMed ID: 37743469
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness and sustainability of deprescribing for hospitalized older patients near end of life: a systematic review.
Cardona M; Stehlik P; Fawzy P; Byambasuren O; Anderson J; Clark J; Sun S; Scott I
Expert Opin Drug Saf; 2021 Jan; 20(1):81-91. PubMed ID: 33213216
[No Abstract] [Full Text] [Related]
8. Deprescribing interventions and their impact on medication adherence in community-dwelling older adults with polypharmacy: a systematic review.
Ulley J; Harrop D; Ali A; Alton S; Fowler Davis S
BMC Geriatr; 2019 Jan; 19(1):15. PubMed ID: 30658576
[TBL] [Abstract][Full Text] [Related]
9. The value of deprescribing in older adults with dementia: a narrative review.
Sawan MJ; Moga DC; Ma MJ; Ng JC; Johnell K; Gnjidic D
Expert Rev Clin Pharmacol; 2021 Nov; 14(11):1367-1382. PubMed ID: 34311630
[No Abstract] [Full Text] [Related]
10. Issues with deprescribing in haemodialysis: a qualitative study of patient and provider experiences.
Bondurant-David K; Dang S; Levy S; Sperlea D; Vanier MC; Gerardi S; David PM
Int J Pharm Pract; 2020 Dec; 28(6):635-642. PubMed ID: 33094884
[TBL] [Abstract][Full Text] [Related]
11. A narrative review of the safety concerns of deprescribing in older adults and strategies to mitigate potential harms.
Reeve E; Moriarty F; Nahas R; Turner JP; Kouladjian O'Donnell L; Hilmer SN
Expert Opin Drug Saf; 2018 Jan; 17(1):39-49. PubMed ID: 29072544
[TBL] [Abstract][Full Text] [Related]
12. Deprescribing in multi-morbid older people with polypharmacy: agreement between STOPPFrail explicit criteria and gold standard deprescribing using 100 standardized clinical cases.
Curtin D; Dukelow T; James K; O'Donnell D; O'Mahony D; Gallagher P
Eur J Clin Pharmacol; 2019 Mar; 75(3):427-432. PubMed ID: 30421220
[TBL] [Abstract][Full Text] [Related]
13. The deprescribing rainbow: a conceptual framework highlighting the importance of patient context when stopping medication in older people.
Todd A; Jansen J; Colvin J; McLachlan AJ
BMC Geriatr; 2018 Nov; 18(1):295. PubMed ID: 30497404
[TBL] [Abstract][Full Text] [Related]
14. Older Patient and Caregiver Perspectives on Medication Value and Deprescribing: A Qualitative Study.
Pickering AN; Hamm ME; Dawdani A; Hanlon JT; Thorpe CT; Gellad WF; Radomski TR
J Am Geriatr Soc; 2020 Apr; 68(4):746-753. PubMed ID: 32067226
[TBL] [Abstract][Full Text] [Related]
15. Are residents of aged care facilities willing to have their medications deprescribed?
Kalogianis MJ; Wimmer BC; Turner JP; Tan EC; Emery T; Robson L; Reeve E; Hilmer SN; Bell JS
Res Social Adm Pharm; 2016; 12(5):784-8. PubMed ID: 26850702
[TBL] [Abstract][Full Text] [Related]
16. The OPTIMIZE patient- and family-centered, primary care-based deprescribing intervention for older adults with dementia or mild cognitive impairment and multiple chronic conditions: study protocol for a pragmatic cluster randomized controlled trial.
Bayliss EA; Shetterly SM; Drace ML; Norton J; Green AR; Reeve E; Weffald LA; Wright L; Maciejewski ML; Sheehan OC; Wolff JL; Gleason KS; Kraus C; Maiyani M; Du Vall M; Boyd CM
Trials; 2020 Jun; 21(1):542. PubMed ID: 32552857
[TBL] [Abstract][Full Text] [Related]
17. Targeted Deprescribing in an Outpatient Hemodialysis Unit: A Quality Improvement Study to Decrease Polypharmacy.
McIntyre C; McQuillan R; Bell C; Battistella M
Am J Kidney Dis; 2017 Nov; 70(5):611-618. PubMed ID: 28416321
[TBL] [Abstract][Full Text] [Related]
18. A-TAPER: A Framework for Deprescribing Medications effectively.
Armistead LT; Sanders KA; Larson CK; Busby-Whitehead J; Ferreri SP
Res Social Adm Pharm; 2022 Aug; 18(8):3358-3361. PubMed ID: 34930683
[TBL] [Abstract][Full Text] [Related]
19. The Role of Deprescribing in Older Adults with Chronic Kidney Disease.
Triantafylidis LK; Hawley CE; Perry LP; Paik JM
Drugs Aging; 2018 Nov; 35(11):973-984. PubMed ID: 30284120
[TBL] [Abstract][Full Text] [Related]
20. An Ecological Approach to Reducing Potentially Inappropriate Medication Use: Canadian Deprescribing Network.
Tannenbaum C; Farrell B; Shaw J; Morgan S; Trimble J; Currie J; Turner J; Rochon P; Silvius J
Can J Aging; 2017 Mar; 36(1):97-107. PubMed ID: 28091333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
